APO RESEARCH · REPORT
Insulin
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
Product & engineering
Understand the product.
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
Selected research
Industry Research
Insulin Industry Research Report 2026
Market perspective
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
The major players in China Insulin market include Novo Nordisk, Eli Lilly, etc. The top 2 players occupy about 60% shares of the whole market. Tianjin and Jiangsu are main markets, they occupy about 60% of the whole market. Regular Human Insulin is the main type, with a share over 60%. Long Acting and Intermediate Acting are the main applications, which holds a share about 70%.
Report Scope
Read the full market overview
This report quantifies the global Insulin market in terms of revenue (US$ million) and, where applicable, sales volume (M Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Insulin Market by Company
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
Insulin Segment by Type
Animal Insulin
Regular Human Insulin
Insulin Analogue
Insulin Segment by Application
Short Acting
Intermediate Acting
Long Acting
Pre-Mix Insulin
Insulin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Insulin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Insulin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Insulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Animal Insulin
- Regular Human Insulin
- Insulin Analogue
Applications
- Short Acting
- Intermediate Acting
- Long Acting
- Pre-Mix Insulin
Companies covered
- Novo Nordisk
- Eli Lilly
- Sanofi-Aventis
- Tonghua Dongbao
- Ganlee
- United Laboratory
- Jiangsu Wanbang
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Insulin Market Size (2021-2032)
- 2.2.2 Global Insulin Sales (2021-2032)
- 2.2.3 Global Insulin Market Average Price (2021-2032)
- 2.3 Insulin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Animal Insulin
- 2.3.3 Regular Human Insulin
- 2.3.4 Insulin Analogue
- 2.4 Insulin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Short Acting
- 2.4.3 Intermediate Acting
- 2.4.4 Long Acting
- 2.4.5 Pre-Mix Insulin
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Insulin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Insulin Sales (M Pcs) of Manufacturers (2021-2026)
- 3.3 Global Insulin Revenue of Manufacturers (2021-2026)
- 3.4 Global Insulin Average Price by Manufacturers (2021-2026)
- 3.5 Global Insulin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Insulin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Insulin, Product Type & Application
- 3.8 Global Manufacturers of Insulin, Established Date
- 3.9 Global Insulin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novo Nordisk
- 4.1.1 Novo Nordisk Company Information
- 4.1.2 Novo Nordisk Business Overview
- 4.1.3 Novo Nordisk Insulin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novo Nordisk Insulin Product Portfolio
- 4.1.5 Novo Nordisk Recent Developments
- 4.2 Eli Lilly
- 4.2.1 Eli Lilly Company Information
- 4.2.2 Eli Lilly Business Overview
- 4.2.3 Eli Lilly Insulin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eli Lilly Insulin Product Portfolio
- 4.2.5 Eli Lilly Recent Developments
- 4.3 Sanofi-Aventis
- 4.3.1 Sanofi-Aventis Company Information
- 4.3.2 Sanofi-Aventis Business Overview
- 4.3.3 Sanofi-Aventis Insulin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi-Aventis Insulin Product Portfolio
- 4.3.5 Sanofi-Aventis Recent Developments
- 4.4 Tonghua Dongbao
- 4.4.1 Tonghua Dongbao Company Information
- 4.4.2 Tonghua Dongbao Business Overview
- 4.4.3 Tonghua Dongbao Insulin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Tonghua Dongbao Insulin Product Portfolio
- 4.4.5 Tonghua Dongbao Recent Developments
- 4.5 Ganlee
- 4.5.1 Ganlee Company Information
- 4.5.2 Ganlee Business Overview
- 4.5.3 Ganlee Insulin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ganlee Insulin Product Portfolio
- 4.5.5 Ganlee Recent Developments
- 4.6 United Laboratory
- 4.6.1 United Laboratory Company Information
- 4.6.2 United Laboratory Business Overview
- 4.6.3 United Laboratory Insulin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 United Laboratory Insulin Product Portfolio
- 4.6.5 United Laboratory Recent Developments
- 4.7 Jiangsu Wanbang
- 4.7.1 Jiangsu Wanbang Company Information
- 4.7.2 Jiangsu Wanbang Business Overview
- 4.7.3 Jiangsu Wanbang Insulin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Jiangsu Wanbang Insulin Product Portfolio
- 4.7.5 Jiangsu Wanbang Recent Developments
5 Global Insulin Market Scenario by Region
- 5.1 Global Insulin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Insulin Sales by Region: 2021-2032
- 5.2.1 Global Insulin Sales by Region: 2021-2026
- 5.2.2 Global Insulin Sales by Region: 2027-2032
- 5.3 Global Insulin Revenue by Region: 2021-2032
- 5.3.1 Global Insulin Revenue by Region: 2021-2026
- 5.3.2 Global Insulin Revenue by Region: 2027-2032
- 5.4 North America Insulin Market Facts & Figures by Country
- 5.4.1 North America Insulin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Insulin Sales by Country (2021-2032)
- 5.4.3 North America Insulin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Insulin Market Facts & Figures by Country
- 5.5.1 Europe Insulin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Insulin Sales by Country (2021-2032)
- 5.5.3 Europe Insulin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Insulin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Insulin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Insulin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Insulin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Insulin Market Facts & Figures by Country
- 5.7.1 South America Insulin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Insulin Sales by Country (2021-2032)
- 5.7.3 South America Insulin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Insulin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Insulin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Insulin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Insulin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Insulin Sales by Type (2021-2032)
- 6.1.1 Global Insulin Sales by Type (2021-2032) & (M Pcs)
- 6.1.2 Global Insulin Sales Market Share by Type (2021-2032)
- 6.2 Global Insulin Revenue by Type (2021-2032)
- 6.2.1 Global Insulin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Insulin Revenue Market Share by Type (2021-2032)
- 6.3 Global Insulin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Insulin Sales by Application (2021-2032)
- 7.1.1 Global Insulin Sales by Application (2021-2032) & (M Pcs)
- 7.1.2 Global Insulin Sales Market Share by Application (2021-2032)
- 7.2 Global Insulin Revenue by Application (2021-2032)
- 7.2.1 Global Insulin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Insulin Revenue Market Share by Application (2021-2032)
- 7.3 Global Insulin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Insulin Value Chain Analysis
- 8.1.1 Insulin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Insulin Production Mode & Process
- 8.2 Insulin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Insulin Distributors
- 8.2.3 Insulin Customers
9 Global Insulin Analyzing Market Dynamics
- 9.1 Insulin Industry Trends
- 9.2 Insulin Industry Drivers
- 9.3 Insulin Industry Opportunities and Challenges
- 9.4 Insulin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst